Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Rani Therapeutics Holdings, Inc. (RANI) had Debt to Equity Ratio of 7.05 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$1.03M |
|
$-30.02M |
|
-- |
|
$1.03M |
|
$54.34M |
|
$-53.31M |
|
$-3.27M |
|
$-56.58M |
|
$-56.58M |
|
$-56.58M |
|
$-56.58M |
|
$-56.58M |
|
$-56.58M |
|
$-53.31M |
|
$-53.30M |
|
28.48M |
|
28.48M |
|
$-1.05 |
|
$-1.05 |
|
| Balance Sheet Financials | |
$29.74M |
|
$1.55M |
|
$6.89M |
|
$36.63M |
|
$19.89M |
|
$9.61M |
|
$13.25M |
|
$33.14M |
|
$3.49M |
|
$3.49M |
|
$3.49M |
|
57.40M |
|
| Cash Flow Statement Financials | |
$-35.50M |
|
$19.81M |
|
$13.59M |
|
$6.36M |
|
$4.26M |
|
$-2.10M |
|
$16.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.50 |
|
-- |
|
-- |
|
0.73 |
|
|
Debt to Equity Ratio |
7.05 |
100.00% |
|
-5186.19% |
|
-5186.19% |
|
-5184.92% |
|
-5504.28% |
|
-2920.04% |
|
$-35.76M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-1619.93% |
|
-1619.93% |
|
-154.46% |
|
-431.74% |
|
$0.06 |
|
$-1.26 |
|
$-1.25 |
|